ERA 2026
This is the logo of the provider
ERA 2026 3 - 6 June 2026

Mechanistic kidney effects of semaglutide by MRI outcomes: a post-hoc analysis of the REMODEL trial

Authors :

Paul D. Hockings1; Patter Bjornstad2,3; David Z.I. Cherney4; Milenta M. Chacko 5;Thomas P. Gunnarsson6; Isabelle Kazes7; Emma T.B. Olesen6; Tina Thethi 8; Menno Pruijm9
Affiliations
View Details Hide Details
This is the logo of the provider
{{ getPageNum(PDFPage) }}
Keywords
Chronic Kidney Disease
Congress short oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)